Most Read Articles
01 Oct 2015
The fatality of hand, foot and mouth disease associated with enterovirus 71 increased in the period of 2008-2012 compared with the number of cases in 1998-2007 based on a systematic review and meta-analysis.
Kavitha G. Shekar, 23 Mar 2016
High school girls (15 to 19 years) on long-acting reversible contraception (LARC) are 60 percent less likely to use condoms compared to contraceptive pill users, findings of a US-based study. This places these girls and their partners at a higher risk for sexually transmitted infections (STIs) including human immunodeficiency virus and reflects their ignorance that condoms are mainly used for pregnancy prevention.
05 Feb 2016
Targeted therapies directed at type 3 secretion protein PcrV and Psl exopolysaccharide are promising approaches against Pseudomonas aeruginosa bloodstream infections, a study suggested.

MIMS Anti-Infective Supplement November 2017

02 Nov 2017
In this issue of MIMS Anti-Infective Supplement, we bring you clinical updates related to infectious diseases, and also a symposium highlight in conjunction with the launch of ceftolozane/tazobactam (Zerbaxa; Merck Sharp & Dohme Sdn Bhd) in Malaysia. 
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
01 Oct 2015
The fatality of hand, foot and mouth disease associated with enterovirus 71 increased in the period of 2008-2012 compared with the number of cases in 1998-2007 based on a systematic review and meta-analysis.
Kavitha G. Shekar, 23 Mar 2016
High school girls (15 to 19 years) on long-acting reversible contraception (LARC) are 60 percent less likely to use condoms compared to contraceptive pill users, findings of a US-based study. This places these girls and their partners at a higher risk for sexually transmitted infections (STIs) including human immunodeficiency virus and reflects their ignorance that condoms are mainly used for pregnancy prevention.
05 Feb 2016
Targeted therapies directed at type 3 secretion protein PcrV and Psl exopolysaccharide are promising approaches against Pseudomonas aeruginosa bloodstream infections, a study suggested.